Canal-U

Mon compte

Résultats de recherche

Nombre de programmes trouvés : 1208
Conférences

le (22m20s)

There could be ten seconds where everyone is connected and you feel really joined by the same thread and it’s really magical

Joint actions require an ability to understand and predict the actions of others far enough into the future to have time to plan and execute matching motor programs. Here I will review experiments in which we have tracked information flow from one brain to another to show that the motor system seems to play a key role in these functions. I will embed this experimental data in a Hebbian learning model, which posits that predictions are the result of synaptic plasticity during self­observation. Jointly this talk will aim to trigger thoughts on how we can ...
Voir la vidéo
Label UNT Conférences

le (4m2s)

Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 : Debate led by Journal Editors: There are too many studies and the quality is variable. Should there be a position statement establishing rules for biomarker studies?

...Title : Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 : Debate led by Journal Editors: There are too many studies and the quality is variable.Should there be a position statement establishing rules for biomarker studies?John JARCHO,...
Voir la vidéo
Label UNT Conférences

le (3m24s)

Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 : Debate led by Journal Editors: There are too many studies and the quality is variable. Should there be a position statement establishing rules for biomarker studies?

...Title : Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 : Debate led by Journal Editors: There are too many studies and the quality is variable.Should there be a position statement establishing rules for biomarker studies?John JARCHO,...
Voir la vidéo
Conférences

le (58m17s)

Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 - Workshop 5 : Will we be able to answer the question of HDL as a therapeutic target after the CETP inhibitor trials? (Robert ROSENSON)

...MODIGLIANI Workshop 5 - Saturday December 1st, 2012THE ATHEROSCLEROSIS TRIALISTS FORUMChairpersons: Wolfgang KOENIG, Ulm, GER - Anthony WIERZBICKI, London, GBRWebcast: Tabassome SIMON, Paris, FRAWill new compounds be able to reduce the residual risk...
Voir la vidéo
Conférences

le (14m26s)

Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 - Workshop 5 : Will we be able to answer the question of HDL as a therapeutic target after the CETP inhibitor trials? (Eric STROES)

...MODIGLIANI Workshop 5 - Saturday December 1st, 2012THE ATHEROSCLEROSIS TRIALISTS FORUMChairpersons: Wolfgang KOENIG, Ulm, GER - Anthony WIERZBICKI, London, GBRWebcast: Tabassome SIMON, Paris, FRAWill new compounds be able to reduce the residual risk...
Voir la vidéo

 
FMSH
 
Facebook Twitter Google+
Mon Compte